Intermittent fasting: miracle or marketing?

Intermittent fasting has been one of the most aggressively marketed dietary protocols of the last decade. The biological story is appealing: compressed eating windows, periods of low insulin, autophagy, metabolic flexibility. The animal studies are striking. The early human data was encouraging. The cultural momentum got ahead of the evidence.

In June 2025, The BMJ published the most comprehensive synthesis to date — a network meta-analysis of 99 randomized clinical trials comparing every major fasting modality with ordinary caloric restriction and free eating. All approaches produced weight loss; none produced clinically meaningful advantages over simply eating less. The single exception, modified alternate-day fasting, edged caloric restriction by 1.29 kg — below the 2 kg threshold considered clinically relevant.

In March 2024, Chen and Zhong (Shanghai Jiao Tong University) presented an analysis from the U.S. national health and nutrition survey at the American Heart Association conference. They followed 20,078 adults for a median of 8 years. Adults whose eating window was less than 8 hours per day had a 91% higher risk of cardiovascular mortality compared to those eating across 12-16 hours. The peer-reviewed publication in 2025 revised the figure upward to 135%.

The signal was strongest in adults with pre-existing cardiovascular disease (66% higher risk). The proposed mechanism, supported by the data: people on tight eating windows had less lean muscle mass — and lean mass loss is itself an established risk factor for cardiovascular mortality.

This study is observational, not a randomized trial. Causality cannot be inferred from it. But when a 20,000-person dataset finds a signal in the opposite direction of what the protocol promises, it deserves attention — not dismissal.

The picture isn't only critical. There are specific situations where the evidence supports fasting — usually as a behavioral structure rather than as metabolic magic.

Adults with prediabetes. Sutton 2018 showed that early time-restricted eating (eating window 6 am-3 pm) improved insulin sensitivity, blood pressure, and oxidative stress — even without weight loss. This finding has held up in subsequent work.

Adults with metabolic syndrome. A 2025 meta-analysis (Song et al., GRADE-evaluated) found genuine improvements in lipid profile and inflammatory markers across multiple intermittent fasting protocols.

Adults who can't restrict calories any other way. The honest argument: for someone who fails to count calories or sustain ordinary restriction, a closed eating window can be a sustainable behavioral structure. That isn't magic. It's habit engineering.

What this means in practice

The most defensible synthesis of the 2024-2026 evidence: intermittent fasting works as a behavioral structure to reduce caloric intake. It does not appear to produce metabolic benefits beyond what equivalent caloric restriction would. And without resistance training and adequate protein, narrow eating windows can produce significant lean-mass loss — with possible cardiovascular consequences if sustained over years.

The honest framing: fasting is a tool, not a treatment. For people who can't sustain ordinary caloric restriction, a closed eating window may be a useful structure. For people who already eat well and train, it adds little. For people with existing cardiovascular conditions, the 2024 mortality signal is reason to avoid extreme windows (under 8 hours) without medical supervision.

The popular claim — that fasting itself produces metabolic magic — has not survived rigorous testing across 99 trials. The protocol works for the same reason every diet works: it reduces calories. Whether you call it intermittent fasting or "stop eating after 8pm" doesn't change the biology.